Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006243
Status:
COMPLETED
Last Update Posted:
2013-01-25
First Post:
2000-09-11
Brief Title:
Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Melanoma |
| Recurrent Melanoma |
Keywords: